PT-141
Overview
Research-use cyclic melanocortin analogue supplied for studies of central melanocortin receptor signaling and hypothalamic pathway models.
- Concentration
- 10 mg
- Stock
- In stock
Product details
PT-141 is a synthetic cyclic melanocortin analogue used in research models of central melanocortin receptor signaling and hypothalamic pathway biology. Pattern lists this material for controlled laboratory research.
Research Targets: MC3R and MC4R signaling, hypothalamic neuropeptide networks, autonomic pathway models.
Key Feature: Cyclic melanocortin receptor agonist format for central pathway research.
Research Focus Areas: Central melanocortin signaling, hypothalamic pathway models, autonomic nervous system signaling, receptor biology.
Common Models: Hypothalamic receptor-binding studies, CNS neuromodulation models, autonomic response paradigms.
Mechanistic Interests: MC3R/MC4R agonism markers, cAMP-mediated signaling, dopaminergic and oxytocinergic pathway crosstalk.
Use Boundary: Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Research context
Peptide guide
Open full guide- Guide profile
- Melanocortin Receptor Agonist
- Composition
- Bremelanotide is a synthetic cyclic heptapeptide melanocortin receptor agonist derived from alpha-MSH analog research.
- Discovery
- Bremelanotide emerged as a more clinically developed melanocortin agonist after earlier Melanotan II observations around sexual arousal.
- Research scope
- The strongest clinical evidence is the Vyleesi HSDD development program in premenopausal women. Other uses, including male sexual function and general libido enhancement, remain separate research/off-label contexts.
- Regulatory status
- FDA-approved for acquired, generalized HSDD in premenopausal women; not approved for broad performance or male enhancement claims
Safety context
- Uncontrolled hypertension
- Known cardiovascular disease
- Use outside labeled population without clinician oversight
Research-use notice: PT-141 should be discussed as bremelanotide with a specific FDA-approved label, not as a generalized libido or performance peptide. This page is educational and should not replace the official prescribing information or qualified medical care.
Full guide includes 10 reference entries.
One kit adds 10 vials to checkout.